Delivery Order SPE2DB22D3401-SPE2DB25FT5HJ
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $60,483.51 contract is a Firm Fixed Price Delivery Order for the supply of Vivitrol 380 mg vials and diluents. The contract has an ultimate completion date of July 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,809.06 firm-fixed-price delivery order is for the supply of 380 mg VIVITROL vials and diluents. The award has a completion date of May 14, 2025 and is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is a delivery order for VIVITROL 380 MG VIAL-DILUENTS, awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract has a ceiling value of $6,007.02 and is a Firm Fixed Price arrangement. The funding agency is the Defense Logistics Agency (DLA), which serves as a critical supplier of medical and pharmaceutical products to federal agencies, particularly the Department of...
- Amerisourcebergen Drug Corp has received a $1,755.74 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply VIVITROL 380 MG VIAL-DILUENTS. The pharmaceutical products will be delivered to a location in Conshohocken, Pennsylvania by December 4, 2023. As the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, will utilize its Corporate Office division to provide the specialty medications and medical supplies...
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a Delivery Order valued at $2,418.54. The contract has an ultimate completion date of April 23, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, particularly the Department of...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,208.52, is a firm fixed-price delivery order for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract has a ceiling value of $4,004.64 and a completion date of July 17, 2025. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and serves as a critical vendor for federal medical procurement needs, particularly for...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VIVITROL 380 MG VIAL-DILUENTS. The $5,485.92 contract has a completion date of July 29, 2024 and is not set-aside. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies, valued up to $999,999,999, to provide a wide range of essential pharmaceutical and medical supplies to...
- This federal contract award, valued at $2,170.07, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract is for the supply of VIVITROL 380 MG VIAL-DILUENTS, a pharmaceutical product, to support...
- This federal contract award, valued at $21,987.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,568,120,563 units of the medication VIVITROL 380 MG VIAL-DILUENTS, with a firm fixed price and an ultimate completion date of May 5, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB25FT5HJDelivery Order
The Defense Logistics Agency (DLA) awarded a $4,004.68 delivery order to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with performance based in Conshohocken, Pennsylvania and completion targeted for July 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a routine pharmaceutical procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for military and veteran healthcare systems through its extensive federal contracting portfolio. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The DLA Troop Support is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen Drug Corp to continue serving federal healthcare customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 7/25/25 |